Related references
Note: Only part of the references are listed.Biomarkers for the diagnosis and management of heart failure
Vincenzo Castiglione et al.
HEART FAILURE REVIEWS (2022)
Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status Results From the EMPEROR-Reduced Trial
Stefan D. Anker et al.
CIRCULATION (2021)
Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure
John R. Teerlink et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure
Deepak L. Bhatt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure
Biykem Bozkurt et al.
EUROPEAN JOURNAL OF HEART FAILURE (2021)
Eligibility of outpatients with chronic heart failure for sodium-glucose co-transporter-2 inhibitors
Gianmarco Angelini et al.
ESC HEART FAILURE (2021)
Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction EMPEROR-Preserved Trial
Milton Packer et al.
CIRCULATION (2021)
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Theresa A. McDonagh et al.
EUROPEAN HEART JOURNAL (2021)
Prognostic Importance of NT-proBNP and Effect of Empagliflozin in the EMPEROR-Reduced Trial
Jr James L. Januzzi et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)
Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure
Biykem Bozkurt et al.
EUROPEAN JOURNAL OF HEART FAILURE (2021)
Multiparametric approach to congestion for predicting long-term survival in heart failure
Francesco Massari et al.
JOURNAL OF CARDIOLOGY (2020)
Imaging in patients with suspected acute heart failure: timeline approach position statement on behalf of the Heart Failure Association of the European Society of Cardiology
Jelena Celutkiene et al.
EUROPEAN JOURNAL OF HEART FAILURE (2020)
Assessment of Limitations to Optimization of Guideline-Directed Medical Therapy in Heart Failure From the GUIDE-IT Trial A Secondary Analysis of a Randomized Clinical Trial
Mona Fiuzat et al.
JAMA CARDIOLOGY (2020)
Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction
Paul W. Armstrong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Sodium-glucose co-transporter 2 inhibitors in heart failure: beyond glycaemic control. A position paper of the Heart Failure Association of the European Society of Cardiology
Petar M. Seferovic et al.
EUROPEAN JOURNAL OF HEART FAILURE (2020)
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
Milton Packer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial
Piotr Ponikowski et al.
LANCET (2020)
Glucose Metabolism in the Kidney: Neurohormonal Activation and Heart Failure Development
Edoardo Gronda et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
Amino-Terminal Pro-B-Type Natriuretic Peptide Implications for Cardiovascular Risk Reduction
James L. Januzzi et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF)
John J. McMurray et al.
EUROPEAN JOURNAL OF HEART FAILURE (2019)
Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction The DEFINE-HF Trial
Michael E. Nassif et al.
CIRCULATION (2019)
Effect of Sacubitril-Valsartan vs Enalapril on Aortic Stiffness in Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial
Akshay S. Desai et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Association of Change in N-Terminal Pro-B-Type Natriuretic Peptide Following Initiation of Sacubitril-Valsartan Treatment With Cardiac Structure and Function in Patients With Heart Failure With Reduced Ejection Fraction
James L. Januzzi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
J. J. V. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
S. D. Solomon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Effects of sacubitril/valsartan on neprilysin targets and the metabolism of natriuretic peptides in chronic heart failure: a mechanistic clinical study
Helene Nougue et al.
EUROPEAN JOURNAL OF HEART FAILURE (2019)
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
S. D. Wiviott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review
Subodh Verma et al.
DIABETOLOGIA (2018)
Brain-Type Natriuretic Peptide and Amino-Terminal Pro-Brain-Type Natriuretic Peptide Discharge Thresholds for Acute Decompensated Heart Failure
Casey N. McQuade et al.
ANNALS OF INTERNAL MEDICINE (2017)
Chronic heart failure as a state of reduced effectiveness of the natriuretic peptide system: implications for therapy
Javier Diez
EUROPEAN JOURNAL OF HEART FAILURE (2017)
ANMCO/ELAS/SIBioC Consensus Document: biomarkers in heart failure
Nadia Aspromonte et al.
EUROPEAN HEART JOURNAL SUPPLEMENTS (2017)
What proportion of patients with chronic heart failure are eligible for sacubitril-valsartan?
Pierpaolo Pellicori et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart Failure Long-Term Registry
Ovidiu Chioncel et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
Effect of Natriuretic Peptide-Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction A Randomized Clinical Trial
G. Michael Felker et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
N-Terminal Pro-B-Type Natriuretic Peptide-Guided Therapy in Chronic Heart Failure Reduces Repeated Hospitalizations - Results From TIME-CHF
Nasser Davarzani et al.
JOURNAL OF CARDIAC FAILURE (2017)
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
Clyde W. Yancy et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Bruce Neal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
A Multiparametric Approach Based on NT-proBNP, ST2, and Galectin3 for Stratifying One Year Prognosis of Chronic Heart Failure Outpatients
Dario Grande et al.
JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE (2017)
Recent advances in point-of-care testing for natriuretic peptides: potential impact on heart failure diagnosis and management
James A. Iwaz et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2016)
Accuracy of bioimpedance vector analysis and brain natriuretic peptide in detection of peripheral edema in acute and chronic heart failure
Francesco Massari et al.
HEART & LUNG (2016)
Echo and natriuretic peptide guided therapy improves outcome and reduces worsening renal function in systolic heart failure: An observational study of 1137 outpatients
Anca Simioniuc et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
N-terminal pro-B-type natriuretic peptide-guided therapy in patients hospitalized for acute heart failure
Valentina Carubelli et al.
JOURNAL OF CARDIOVASCULAR MEDICINE (2016)
Prognostic Implications of Changes in N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Heart Failure
Michael R. Zile et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Angiotensin Receptor Neprilysin Inhibition in Heart Failure: Mechanistic Action and Clinical Impact
Jonathan Buggey et al.
JOURNAL OF CARDIAC FAILURE (2015)
Soluble Neprilysin Is Predictive of Cardiovascular Death and Heart Failure Hospitalization in Heart Failure Patients
Antoni Bayes-Genis et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Angiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure
Milton Packer et al.
CIRCULATION (2015)
Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure
John J. V. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Changes of Natriuretic Peptides Predict Hospital Admissions in Patients With Chronic Heart Failure A Meta-Analysis
Gianluigi Savarese et al.
JACC-HEART FAILURE (2014)
Are Serial BNP Measurements Useful in Heart Failure Management? Serial Natriuretic Peptide Measurements Are Useful in Heart Failure Management
James L. Januzzi et al.
CIRCULATION (2013)
Adding serial N-terminal pro brain natriuretic peptide measurements to optimal clinical management in outpatients with systolic heart failure: a multicentre randomized clinical trial (NorthStar monitoring study)
Morten Schou et al.
EUROPEAN JOURNAL OF HEART FAILURE (2013)
Effects of Nesiritide and Predictors of Urine Output in Acute Decompensated Heart Failure Results From ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide and Decompensated Heart Failure)
Stephen S. Gottlieb et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Primary Results of the HABIT Trial (Heart Failure Assessment With BNP in the Home)
Alan Maisel et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Rehospitalization for Heart Failure Predict or Prevent?
Akshay S. Desai et al.
CIRCULATION (2012)
Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study
Karen Barnett et al.
LANCET (2012)
Thirty years of the heart as an endocrine organ: physiological role and clinical utility of cardiac natriuretic hormones
Aldo Clerico et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2011)
Comparison of Mass Spectrometry and Clinical Assay Measurements of Circulating Fragments of B-Type Natriuretic Peptide in Patients With Chronic Heart Failure
Wayne L. Miller et al.
CIRCULATION-HEART FAILURE (2011)
COMPARISON OF THE DIAGNOSTIC CHARACTERISTICS OF TWO B-TYPE NATRIURETIC PEPTIDE POINT-OF-CARE DEVICES
Richard Ro et al.
JOURNAL OF EMERGENCY MEDICINE (2011)
Use of Amino-Terminal Pro-B-Type Natriuretic Peptide to Guide Outpatient Therapy of Patients With Chronic Left Ventricular Systolic Dysfunction
James L. Januzzi et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Management of Chronic Heart Failure Guided by Individual N-Terminal Pro-B-Type Natriuretic Peptide Targets Results of the PRIMA (Can PRo-brain-natriuretic peptide guided therapy of chronic heart failure IMprove heart fAilure morbidity and mortality?) Study
Luc W. M. Eurlings et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
National Heart, Lung, and Blood Institute Working Group on Emergency Department Management of Acute Heart Failure Research Challenges and Opportunities
W. Frank Peacock et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
The Role of N-terminal PRO-Brain Natriuretic Peptide and Echocardiography for Screening Asymptomatic Left Ventricular Dysfunction in a Population at High Risk for Heart Failure. The PROBE-HF Study
Irene Betti et al.
JOURNAL OF CARDIAC FAILURE (2009)
N-Terminal Pro-B-Type Natriuretic Peptide-Guided Treatment for Chronic Heart Failure
John G. Lainchbury et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
NT-proBNP has a high negative predictive value to rule-out short-term cardiovascular events in patients with diabetes mellitus
Martin Huelsmann et al.
EUROPEAN HEART JOURNAL (2008)
B-Type natriuretic peptide-guided treatment for predicting outcome in patients hospitalized in sub-intensive care unit with acute heart failure
Roberto Valle et al.
JOURNAL OF CARDIAC FAILURE (2008)
Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial)
Serge Masson et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Comparison of Hand-Carried Ultrasound Assessment of the Inferior Vena Cava and N-Terminal Pro-Brain Natriuretic Peptide for Predicting Readmission After Hospitalization for Acute Decompensated Heart Failure
Sascha N. Goonewardena et al.
JACC-CARDIOVASCULAR IMAGING (2008)
Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure -: The STARS-BNP multicenter study
Patrick Jourdain et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications
A Clerico et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study
JL Januzzi et al.
AMERICAN JOURNAL OF CARDIOLOGY (2005)
How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review
JA Doust et al.
BRITISH MEDICAL JOURNAL (2005)
N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients
P Bettencourt et al.
CIRCULATION (2004)
Effects of valsartan on circulating brain natriuretic peptide and norepinephrine in symptomatic chronic heart failure - The Valsartan Heart Failure Trial (Val-HeFT)
R Latini et al.
CIRCULATION (2002)
Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure
AS Maisel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: A pilot study
R Kazanegra et al.
JOURNAL OF CARDIAC FAILURE (2001)
A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: A pilot study
V Cheng et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2001)
Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations
RW Troughton et al.
LANCET (2000)
Share Paper
